Learn about new data relating to genetics, treatment, digital health, and COVID-19, presented at the Movement Disorder Society’s virtual congress (MDS 2021), held on 17-22 September.
Here, Dr Thomas Tropea (University of Pennsylvania, Philadelphia, USA) provides commentary on a selection of the most important presentations at MDS 2021, highlighting the implications for care.
Click on the links within the text for more details of the new findings and advances, from Neurodiem’s daily coverage of the event.
Well over 1,000 original research studies were presented at the 2021 virtual congress of the International Parkinsonism and Movement Disorder Society. The role of genetic testing emerged as one of the major themes, alongside insights into how digital health applications can help improve care, and the impact of the COVID-19 pandemic on patients and specialists.